Meet Ardigen phenAID, a user-friendly application powered by Artificial Intelligence for High Content Screening data analysis
Ardigen phenAID platform transforms drug discovery to identify better candidate drugs. PhenAID takes a multimodal approach, leveraging multiple input sources including phenotypic, structural and omics data to facilitate virtual screening, hit ID, mode of action/biological property prediction and optimization of candidate drugs. PhenAID provides researchers with access to the most recent advancements in AI and computer vision without the need for hiring a team of experts.
Discover more about how Ardigen as a Supporting Partner of the JUMP-CP Consortium can bridge the gap between Cell Imaging and Small Molecule design with the PhenAID platform.
Watch the video where Lead Molecular Biologist Magdalena Otrocka, PhD presents our cutting-edge platform that will simplify the process of reaching your scientific objectives.
Transform Your Drug Discovery with us! Want to know more or try Ardigen phenAID? Read more!